Updates on the Translational Value of Idiopathic Pulmonary Fibrosis Models Across Species: Deeper Insights Through Comparative Pathology
4 affiliations
- 1Institute of Clinical Physiology, National Research Council, Via Fiorentina 1, 53100 Siena, Italy
- 2Institute of Crystallography, National Research Council, Strada Provinciale 35d, n. 9, Montelibretti, 00010 Rome, Italy
- 3Department of Life Sciences, University of Siena, 53100 Siena, Italy
- 4Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy
Abstract
Over the past few decades, advances in comparative pathology have strengthened the potential translational value of animal models of Idiopathic Pulmonary Fibrosis (IPF). The integration of human-relevant diagnostic biomarkers into preclinical studies, such as advanced imaging techniques and standardized histopathological methods, has improved the comparability of experimental findings with human disease. Naturally occurring fibrotic lung diseases in some breeds of companion dogs and cats and induced disease models in laboratory rodents show varying degrees of similarity to human IPF. They represent valuable comparative medicine tools to better understand disease mechanisms and test new therapies, each with advantages and limitations. Critically evaluating their complementarity is essential for gaining reliable insights into disease processes through preclinical animal studies and for developing effective treatments. This comprehensive review aims to update current knowledge of these animal models of IPF, focusing on comparative pathology, imaging, and histological features and evaluating their respective strengths, limitations, and translational relevance within the conceptual framework of “One Health, One Medicine, One Pathology”. By exploiting convergent pathophysiological processes across species, this interdisciplinary collaborative paradigm aims to promote the effective use of model organisms in biomedical research and foster mutual benefits for both humans and animals.
Related
- Reply: Comparative Clinical Outcomes of Nintedanib and Pirfenidone in Idiopathic Pulmonary Fibrosis: A Five-Year Real-Life Study
- Absolute and lung volume-normalized deep learning-derived pulmonary vascular measures in idiopathic pulmonary fibrosis: distinct clinical associations and the role of lung volume in prognosis
- Obesity and the risk of idiopathic pulmonary fibrosis: a nationwide population-based study.
- Metabolomic Profiles Predict the Risk of Idiopathic Pulmonary Fibrosis
- Nomogram models integrating multiregion radiomics, quantitative computed tomography, and clinical indicators for distinguishing connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis and improving the prediction of gender-age-physiology stage
BibTeX
@article{gargiulo2026updates,
title = {{Updates on the Translational Value of Idiopathic Pulmonary Fibrosis Models Across Species: Deeper Insights Through Comparative Pathology}},
author = {Sara Gargiulo and Matteo Gramanzini and Denise Bonente and Virginia Barone},
journal = {Biomolecules},
year = {2026},
month = oct,
doi = {10.3390/biom16101519},
url = {https://www.mdpi.com/2218-273X/16/10/1519},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Updates on the Translational Value of Idiopathic Pulmonary Fibrosis Models Across Species: Deeper Insights Through Comparative Pathology
AU - Sara Gargiulo
AU - Matteo Gramanzini
AU - Denise Bonente
AU - Virginia Barone
PY - 2026
DA - 2026/10/01
JO - Biomolecules
DO - 10.3390/biom16101519
UR - https://www.mdpi.com/2218-273X/16/10/1519
AB - Over the past few decades, advances in comparative pathology have strengthened the potential translational value of animal models of Idiopathic Pulmonary Fibrosis (IPF). The integration of human-relevant diagnostic biomarkers into preclinical studies, such as advanced imaging techniques and standardized histopathological methods, has improved the comparability of experimental findings with human disease. Naturally occurring fibrotic lung diseases in some breeds of companion dogs and cats and induced disease models in laboratory rodents show varying degrees of similarity to human IPF. They represent valuable comparative medicine tools to better understand disease mechanisms and test new therapies, each with advantages and limitations. Critically evaluating their complementarity is essential for gaining reliable insights into disease processes through preclinical animal studies and for developing effective treatments. This comprehensive review aims to update current knowledge of these animal models of IPF, focusing on comparative pathology, imaging, and histological features and evaluating their respective strengths, limitations, and translational relevance within the conceptual framework of “One Health, One Medicine, One Pathology”. By exploiting convergent pathophysiological processes across species, this interdisciplinary collaborative paradigm aims to promote the effective use of model organisms in biomedical research and foster mutual benefits for both humans and animals.
SN - 2218-273X
ER -